GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System

The device behind the data

GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System

Designed for the demands of TEVAR

The TAG® Conformable Device combines a trusted stent graft with a unique delivery system designed for the complex, angulated anatomy of the thoracic aorta.

The difference is control

The GORE® ACTIVE CONTROL System provides an intermediate stage before full deployment—at 50% diameter—giving you the confidence of control.

Visualize, correct for parallax, reposition and refine angulation, all in real time.

The delivery system provides two opportunities to adjust angulation as needed.

Angulation adjustment at full deployment.

The difference is precision 

Unique angulation control is available at both intermediate and full deployment, empowering you with the precision to adjust for 360° wall apposition and seal along inner curve of the aorta.

Vector image of a single arrow hitting a bullseye on a target.

98% reported that proximal wall apposition was acceptable at procedural completion1

Deployment animation demonstrating unique delivery system capabilities.

Deliver and deploy with precision in complex anatomy. 

The difference is conformability

Enhanced control and exceptional conformability combine to help minimize the risk of adverse events requiring reintervention.

Vector image of a small and large droplet crossed out.

Zero Type III endoleaks reported in 5-year data across all etiologies*,2-4

Setting a standard of conformability

The TAG® Conformable Device exhibited the lowest spring back in bench-top analysis.

Benchtop evaluations are intended to demonstrate relative physical characteristics and may not correlate to clinical results. All devices were tested under equivalent situations. Complete information and data are on file.

Adapting to aortic anatomy

Our device adapts to the aorta by design, rather than the aorta adapting to the device. See the impact in real patient anatomy over 5 years of follow-up:

Five-year follow-up imaging demonstrates unique anatomical adaptability.

Pre-treatment

Five-year follow-up imaging demonstrates unique anatomical adaptability.

1 Year

Five-year follow-up imaging demonstrates unique anatomical adaptability.

2 Years

Five-year follow-up imaging demonstrates unique anatomical adaptability.

3 Years

Five-year follow-up imaging demonstrates unique anatomical adaptability.

4 Years

Five-year follow-up imaging demonstrates unique anatomical adaptability.

5 Years

The difference is meaningful

The TAG® Conformable Device harnesses more than 25 years of TEVAR experience and evidence. 

That’s just one number worth counting on:
 

Vector image of the number 0

Zero migrations,† fractures or compressions* reported in 5 years across all etiologies
 

Vector image of the CTAG product simplified

1st device approved for endovascular treatment of all etiologies

Vector image of Thoracic Aorta

1st TEVAR solution to feature angulation control

Vector image of a calendar with a 5-pointed star

10+ years of follow-up

* No reported compressions, fractures or Type III endoleaks. 

† Migrations are reported as those requiring reintervention.

  1. W. L. Gore & Associates. Observational Registry Characterizing the Performance and Feature Use of the GORE® TAG® Conformable Thoracic Stent Graft Featuring ACTIVE CONTROL System. NLM Identifier: NCT03286400. Published September 18, 2017. Updated December 17, 2020. Accessed February 23, 2021. https://clinicaltrials.gov/ct2/show/NCT03286400
  2. W. L. Gore & Associates. Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection. NLM Identifier: NCT00908388. Published May 25, 2009. Updated October 27, 2017. Accessed June 7, 2022. https://clinicaltrials.gov/ct2/show/NCT00908388
  3. W. L. Gore & Associates. Evaluation of the GORE Conformable TAG® for Treatment of Traumatic Transection. NLM Identifier: NCT00917852. Published June 10, 2009. Updated August 25, 2017. Accessed June 7, 2022. https://clinicaltrials.gov/ct2/show/NCT00917852
  4. W. L. Gore & Associates. An Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for the Primary Treatment of Aneurysm of the Descending Thoracic Aortic. NLM Identifier: NCT00874250. Published April 2, 2009. Updated August 25, 2017. Accessed June 7, 2022. https://clinicaltrials.gov/ct2/show/NCT00874250
     

Related to this product

Watch procedural videos image

Watch procedural videos

The power to be precise thumbnail

The power to be precise

View product brochure

Promotes hemodynamic stability thumbnail

Promotes hemodynamic stability

See how

eIFU Symbol

INDICATIONS FOR USE IN THE U.S.: The GORE® TAG® Conformable Thoracic Stent Graft is intended for endovascular repair of all lesions of the descending thoracic aorta, including: isolated lesions in patients who have appropriate anatomy, including: adequate iliac/femoral access, aortic inner diameter in the range of 16-42 mm, ≥ 20 mm non-aneurysmal aorta proximal and distal to the lesion; Type B dissections in patients who have appropriate anatomy, including: adequate iliac/femoral access, ≥ 20 mm landing zone proximal to the primary entry tear; proximal extent of the landing zone must not be dissected, diameter at proximal extent of proximal landing zone in the range of 16-42 mm. CONTRAINDICATIONS: Patients with known sensitivities or allergies to the device materials; patients who have a condition that threatens to infect the graft. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

24AR1091-EN01

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.